closed call

Call: Innovation platforms for advanced therapies of the future

Logo
Programme	Horizon 2020
Acronym	H2020
Type of Fund	Action programme
Description of programme "Horizon 2020"	Horizon 2020 is the biggest EU Research and Innovation programme with nearly 80 billion € of funding available over 7 years (2014 to 2020). Apart from classic research projects, Horizon 2020 also funds innovation projects and pilot-projects in different fields. The programme is divided into three different sections: Excellent Science Industrial Leadership Societal Challenges Countries eligible for funding are: The EU-Member States, Iceland, Norway, Albania, Bosnia and Herzegovina, the former Yugoslav Republic of Macedonia, Montenegro, Serbia, Turkey, Moldova, Switzerland, Ukraine, Faroe Islands, Israel, Tunisia, Georgia, Armenia.
Link	Link to Programme
Description of programme "Health, Demographic Change and Wellbeing"	Responding to the challenge of an aging population, research and innovation (R&I) under Horizon 2020 is an investment in better health for all. It aims to keep older people active and independent for longer and supports the development of new, safer and more effective interventions. R&I under Horizon 2020 also contributes to the sustainability of health and care systems.
Call	Innovation platforms for advanced therapies of the future
Description of call "Innovation platforms for advanced therapies of the future "	Projects should create knowledge, testing and exploitation platforms around innovative concepts for advanced therapy development. Platforms should comprise the components and expertise necessary to create a solid foundation on which to build possible new therapeutic approaches and/or aim to overcome particular development bottlenecks. Possible components could include studying the basic biology of the potential therapy and investigating its mode of action, proof of concept (in vitro, in animal models – where necessary - or first-in–man studies); safety, efficacy, characterisation, refinement and manufacturing of the product could be considered. Projects should also propose a business model for exploiting results and carry out appropriate outreach and public information activities.
Link	Link to Call
Thematic Focus	Biotechnology, Health, Research
Funding area	EU Member States Albania / Shqipëria Bosnia and Herzegovina Former Yugoslav Republic of Macedonia / поранешна југословенска Република Македонија Iceland / Ísland Moldova Montenegro / Crna Gora/Црна Гора Norway / Norge Serbia / Сpбија Switzerland / Schweiz / Suisse / Svizzera Turkey / Türkiye Ukraine / Україна Oukraïna Others
Origin of Applicant	EU Member States Albania / Shqipëria Bosnia and Herzegovina Former Yugoslav Republic of Macedonia / поранешна југословенска Република Македонија Iceland / Ísland Moldova Montenegro / Crna Gora/Црна Гора Norway / Norge Serbia / Сpбија Switzerland / Schweiz / Suisse / Svizzera Turkey / Türkiye Ukraine / Україна Oukraïna Others
Eligible applicants	Education and Training Centres, Research Institution, Federal State / Region / City / Municipality / Local Authority, Lobby Group / Professional Association / Trade Union, Small and Medium Sized Enterprises, SMEs (between 10 and 249 employees), International Organization, Microenterprises (fewer than 10 employees), NGO / NPO, Public Services, Other, National Government, Start Up Company, University, Enterprise (more than 250 employees or not defined), Association
Applicant details	All legal entities located in the EU or in Third Countries can participate in Horizon 2020.
Project Partner	Yes
Project Partner Details	As a principle all projects (except coordination and support activities) must comprise at least 3 partners from at least 3 EU Member States or other eligible countries.
Further info	Open access must be granted to all scientific publications.
Type of Funding	Grant
Financial details	budget amount: 12-15 Mio. € per proposal Co- funding: max. 100%
Submission	Participant Portal
Contact Details	Link to the National Contact Point Finder.